Topic: Gabitril
Nothing ruins a perfectly fine day quite like a headache. The pain can be impeding, disorienting and sometimes even nauseating. Roughly 45 million...
Investment Opinion. . MAP Pharmaceuticals (MAPP) is poised to introduce its first commercial product, Levadex (inhaled dihydroergotamine) that is...
Zelrix, developed by Nupathe (PATH), is an old molecule with a new delivery mechanism for the treatment of migraines. Zelrix is a transdermal patch...
Pharmaceuticals and fat . About 70% of people in the United States are overweight and, in a cruel catch-22, many of the drugs used to treat...
On Monday, POZEN Inc. (POZN) announced more details regarding a transaction in which they sold most of the future royalty and milestone payments...
The Consumer Justice Foundation, a for-profit corporation that provides free online resources for consumers that allow them to remain informed with...
0 . NuPathe, a maker of neurological and psychiatric medicines, fell 35 percent in New York trading after failing to win U.S. approval for the...
I have suffered from migraines for about twenty years now. They are less frequent and of lower intensity than they were in my 30s, but I still...
Depakote Birth Injury Resources Announces That Birth Defect Victims May Qualify for Depakote Lawsuits . . As lawsuits against the makers of the...
Topamax Birth Injury Resources Advises of Recent FDA Changes to the Topamax Pregnancy Category Due To Potential Birth Defect Risk . . Topamax is...